Document is current
Any future updates will be listed below
-
Authors
Schwarz, Christopher G. https://orcid.org/0000-0002-1466-8357
Tosakulwong, Nirubol
Senjem, Matthew L.
Gunter, Jeffrey L.
Therneau, Terry M.
Vemuri, Prashanthi
Lowe, Val J.
Jack, Clifford R. Jr.
- License Information
-
More Information
Article History
Received: 7 December 2017
Accepted: 20 April 2018
First Online: 9 May 2018
Competing Interests
: Christopher Schwarz receives research funding from the NIH. Nirubol Tosakulwong reports no disclosures. Matthew Senjem holds stock in Align Technology, Inc., Gilead Sciences, Inc., Globus Medical Inc., Inovio Pharmaceuticals, Inc., Johnson & Johnson, LHC Group, Inc., Medtronic, Mesa Laboratories, Inc., Natus Medical Incorporated, Varex Imaging Corporation. Jeffrey Gunter reports no disclosures. Terry Therneau reports no disclosures. Prashanthi Vemuri is funded by the NIH. Val Lowe consults for Bayer Schering Pharma, Piramal Life Sciences and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals and the NIH (NIA, NCI). Clifford Jack has provided consulting services for Eli Lily. He receives research funding from the NIH (R01-AG011378, U01-AG024904, RO1 AG041851, R01 AG37551, R01AG043392, U01-AG06786), and the Alexander Family Alzheimer’s Disease Research Professorship of the Mayo Clinic.
